CPIX: Cumberland Corp Kapitalizatsiyaning daromadga nisbati

Cumberland Pharmaceuticals Inc (CPIX) brendining ramzi va logotipi

Cumberland Pharmaceuticals gastroenterologiya va shifoxonalar uchun FDA tomonidan tasdiqlangan nishey mahsulotlar portfeli orqali risklarni minimallashtiradi. GURU.Markets grafiklaridagi aniq P/S koeffitsiyenti tebranishlari tushumning bozor qiymatini namoyish etadi, bunda 3.50 qiymati metrika darajasini aks ettiradi. Biznesning o'sishi yangi dori vositalarini mavjud distribyutsiya kanallariga integratsiya qilishga bog'liq. Texnologlar jamoasining barqarorligi va xodimlarning past aylanish darajasi barqaror rivojlanishni ta'minlaydi.

Narxning daromadga nisbati: Cumberland Pharmaceuticals Inc. (CPIX) 04.07.2022 - 14.11.2026 uchun

Cumberland Pharma (CPIX) kompaniyasining tahliliy kesimlari

Kompaniyaning fundamental tahlili:cumberlandpharma.com, CPIX
Cumberland Pharmaceuticals Inc. tovar namunasi

P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga nisbatan belgilaydi. Ushbu ko'rsatkich spekulyativ talabni haqiqiy tijorat natijalari bilan solishtirib, aktivning haddan tashqari sotib olingan yoki past baholangan sohalarini aniqlaydi. Cumberland Pharmaceuticals (CPIX) uchun 3.50 ning joriy qiymati shifoxona dori vositalari savdosi barqaror foyda generatori bo'lib xizmat qiladigan modelning chidamliligini tasdiqlaydi. Tarixiy P/S ko'rsatkichini tahlil qilish orqali investor chuqur korreksiya xavflaridan qochgan holda, optimal kirish nuqtasini aniqlashi mumkin.

Cumberland Pharmaceuticals raqobatchilari

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori KVUE (Kenvue)|VRNA - Kapitalizatsiyaning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|LGND - P/S multiplikatori|Amneal Pharmaceuticals (AMRX) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati perrigo.com|ALVO (Alvotech SA) - P/S multiplikatori|Narxning daromadga nisbati LQDA|P/S multiplikatori GLPG|ANIP - Sotuvga nisbatan narx|Narxning daromadga nisbati MannKind Corporation MNKD|Bozor kapitallashuvining daromadga nisbati AMPH|PCRX - Narxning daromadga nisbati|SPRY: Narxning daromadga nisbati|TBPH: P/S multiplikatori|Aquestive Corp (AQST) - P/S multiplikatori|Narxning daromadga nisbati scPharmaceuticals, Inc.|Kapitalizatsiya va daromad nisbati TECX (Tectonic)|P/S multiplikatori TNXP|sxtchina.com - Kapitalizatsiya va daromad nisbati|Eupraxia Pharmaceuticals Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati BHST|EXOZ - Narxning daromadga nisbati|Narxning sotuvga nisbati ORMP|ENTX: P/S multiplikatori|MindWalk Holdings, Inc. - Bozor kapitallashuvining daromadga nisbati|ABVC (ABVC BioPharma Inc) - P/S multiplikatori|P/S multiplikatori Quantum BioPharma Corp|Narxning daromadga nisbati FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Rani Therapeutics Holdings, Inc. RANI|SNYR - Kapitalizatsiyaning daromadga nisbati|Rallybio Corp. - P/S multiplikatori|LEXX - P/S multiplikatori|PULM: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pheton Holdings|APM (Aptorum Group Ltd) - P/S multiplikatori|Sotuvga nisbatan narx Lyra Therapeutics Inc. LYRA|Kapitalizatsiyaning daromadga nisbati IBO (Impact BioMedical)|P/S multiplikatori tnfpharma.com (TNFA)|cbdMD - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati PRFX (painreform.com)|Auris Medical - P/S multiplikatori|Narx/daromad koeffitsiyenti Lipella Pharmaceuticals Inc LIPO|OPTN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharma|PROC (Procaps Group S.A.) - P/S multiplikatori|P/S multiplikatori petrospharma.com|Narxning daromadga nisbati Qilian International Holding (QLI)|Narxning daromadga nisbati SLRN (Acelyrin Inc.)|Narxning daromadga nisbati TFF Pharma TFFP